คำถามที่พบบ่อย

What is Axicabtagene Ciloleucel used for?

A CAR-T cell therapy in which a patient's own T cells are genetically engineered to express a chimeric antigen receptor targeting CD19, a protein on the surface of certain B-cell cancers. The modified cells are infused back to seek out and destroy cancer cells.

Is Axicabtagene Ciloleucel an approved drug?

Yes, Axicabtagene Ciloleucel is an approved drug. It has reached clinical phase 4. It is classified as a Gene.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

• ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989989. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.